Human Genome Epidemiology Literature Finder
Records 1 - 25 (of 25 Records) |
Query Trace: Thrombosis and PON1[original query] |
---|
Polymorphisms of the paraoxonase gene and risk of preterm delivery. Epidemiology (Cambridge, Mass.) 2004 Jul 15 (4): 466-70. Chen Dafang, Hu Yonghua, Chen Changzhong, Yang Fan, Fang Zhian, Wang Lihua, Li Jianpi |
Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus. Diabetic medicine : a journal of the British Diabetic Association 2004 Aug 21 (8): 837-44. Murata M, Maruyama T, Suzuki Y, Saruta T, Ikeda |
The association of the PON1 Q192R polymorphism with complications and outcomes of pregnancy: findings from the British Women's Heart and Health cohort study. Paediatric and perinatal epidemiology 2006 May 20 (3): 244-50. Lawlor Debbie A, Gaunt Tom R, Hinks Lesley J, Davey Smith George, Timpson Nick, Day Ian N M, Ebrahim Sh |
Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach. Clinica chimica acta; international journal of clinical chemistry 2009 Apr 402 (1-2): 189-92. Zee Robert Y L, Bubes Vadim, Shrivastava Sanjay, Ridker Paul M, Glynn Robert |
Genetic association between single nucleotide polymorphisms in the paraoxonase 1 (PON1) gene and small-for-gestational-age birth in related and unrelated subjects. American journal of epidemiology 2010 May 171 (9): 999-1006. Infante-Rivard Clai |
Paraoxonase-1 is a major determinant of clopidogrel efficacy. Nature medicine 2011 Jan 17 (1): 110-6. Bouman Heleen J, Schömig Edgar, van Werkum Jochem W, Velder Janna, Hackeng Christian M, Hirschhäuser Christoph, Waldmann Christopher, Schmalz Hans-Günther, ten Berg Jurriën M, Taubert Di |
No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting. European heart journal 2011 Jul 32 (13): 1605-13. Sibbing Dirk, Koch Werner, Massberg Steffen, Byrne Robert A, Mehilli Julinda, Schulz Stefanie, Mayer Katharina, Bernlochner Isabell, Schömig Albert, Kastrati Adn |
Predicting clopidogrel response using DNA samples linked to an electronic health record. Clinical pharmacology and therapeutics 2011 Dec . Delaney JT, Ramirez AH, Bowton E, Pulley JM, Basford MA, Schildcrout JS, Shi Y, Zink R, Oetjens M, Xu H, Cleator JH, Jahangir E, Ritchie MD, Masys DR, Roden DM, Crawford DC, Denny JC |
Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction. International journal of cardiology 2013 Sep 167 (6): 2882-8. Verschuren Jeffrey J W, Boden Helèn, Wessels Judith A M, van der Hoeven Bas L, Trompet Stella, Heijmans Bastiaan T, Putter Hein, Guchelaar Henk-Jan, Schalij Martin J, Jukema J Wout |
Paraoxonase-1 is not a major determinant of stent thrombosis in a Taiwanese population. PloS one 2012 7 (6): e39178. Chen Dong-Yi, Wang Chao-Yung, Wen Ming-Shien, Lee Tsong-Hai, Chu Yen, Hsieh Ming-Jer, Chang Shang-Hung, Lee Cheng-Hung, Wang Jian-Liang, Chen Chun-Chi, Lu Laing-Suei, Lee Ming-Ta, Yeh San-Jou, Lin Fun-Chiung, Hsieh I-Cha |
Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study. Journal of the American College of Cardiology 2012 May 59 (22): 1928-37. Price Matthew J, Murray Sarah S, Angiolillo Dominick J, Lillie Elizabeth, Smith Erin N, Tisch Rebecca L, Schork Nicholas J, Teirstein Paul S, Topol Eric J, |
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis. Journal of thrombosis and haemostasis : JTH 2012 Jul 10 (7): 1242-51. Reny J-L, Combescure C, Daali Y, Fontana P, |
Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response. Clinical pharmacology : advances and applications 2012 4 13-20. Kreutz Rolf P, Nystrom Perry, Kreutz Yvonne, Miao Jia, Desta Zeruesenay, Breall Jeffrey A, Li Lang, Chiang Chienwei, Kovacs Richard, Flockhart David A, Jin Y |
Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention. European journal of clinical pharmacology 2012 Nov . Tang XF, Wang J, Zhang JH, Meng XM, Xu B, Qiao SB, Wu YJ, Chen J, Wu Y, Chen JL, Gao RL, Yuan JQ, Yang YJ |
[Relevance of CYP2C19 2 regarding platelet reactivity in patients with acute coronary syndrome treated with clopidogrel]. Medicina clínica 2014 Jul 143 (1): 6-12. Cano Pedro, Consuegra-Sánchez Luciano, Conesa Pablo, Torres-Moreno Daniel, Jaulent Leticia, Dau Derek, Picó Francisco, Villegas Manu |
Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCI. PloS one 2013 8 (2): e52779. Park Kyung Woo, Park Jin Joo, Kang Jeehoon, Jeon Ki-Hyun, Kang Si-Hyuck, Han Jung-Kyu, Lee Sang Eun, Yang Han-Mo, Lee Hae-Young, Kang Hyun-Jae, Koo Bon-Kwon, Oh Byung-Hee, Park Young-Bae, Kim Hyo-S |
Relationships between PON1 Q192R polymorphism and clinical outcome of antiplatelet treatment after percutaneous coronary intervention: a meta-analysis. Molecular biology reports 2014 Sep 41 (9): 6263-73. Li Ping, Bu Shu-Hong, Lu Xiao-Tong, Li Li-Xia, Xu A-Jing, Tang Yue-Nian, Zhang Ji |
The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease. Pharmacogenetics and genomics 2014 Apr 24 (4): 204-10. Xie Cheng, Ding Xiaoliang, Gao Jie, Wang Haipeng, Hang Yongfu, Zhang Hua, Zhang Jingjing, Jiang Bin, Miao Liy |
Effects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery disease. PloS one 2014 9 (10): e110188. Tresukosol Damrus, Suktitipat Bhoom, Hunnangkul Saowalak, Kamkaew Ruttakarn, Poldee Saiphon, Tassaneetrithep Boonrat, Likidlilid At |
Paraoxonase 1 (Q192R) gene polymorphism, coronary heart disease and the risk of a new acute coronary event. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis 2016 Nov . Martínez-Quintana Efrén, Rodríguez-González Fayna, Medina-Gil José María, Garay-Sánchez Paloma, Tugores Anton |
The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. Basic & clinical pharmacology & toxicology 2017 Jan . Saydam Faruk, De?irmenci ?rfan, Birdane Alparslan, Özdemir Mahmut, Ulus Taner, Özbayer Cansu, Çolak Ertu?rul, Ata Necmi, Güne? Hasan Vey |
Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort. Pharmacogenomics 2018 12 20 (2): 75-83. Melin Kyle, Moon Jee-Young, Qi Qibin, Hernandez-Suarez Dagmar F, Duconge Jorge, Hua Simin, Gonzalez Sara, Zeng Donglin, Kaplan Robert |
Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study. Scientific reports 2018 1 8 (1): 1229. Joo Hyung Joon, Ahn Sung Gyun, Park Jae Hyoung, Park Ji Young, Hong Soon Jun, Kim Seok-Yeon, Choi WoongGil, Gwon HyeonCheol, Lim Young-Hyo, Kim Weon, Kang Woong Chol, Cho Yun-Hyeong, Kim Yong Hoon, Yoon JungHan, Shin WonYong, Hong Myeong-Ki, Garg Scot, Jang Yangsoo, Lim Do-S |
Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients. Scientific reports 2021 Mar 11 (1): 6773. Grzegorzewska Alicja E, Adamska Paulina, Iwa?czyk-Skalska Ewa, Ostromecka Kamila, Niepolski Leszek, Marcinkowski Wojciech, Mostowska Adrianna, Warcho? Wojciech, ?aba Czes?aw, Jagodzi?ski Pawe? |
Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development. Frontiers in genetics 2022 13 966413. Vavlukis Marija, Vavlukis Ana, Krsteva Katerina, Topuzovska Son |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: